doxazosin has been researched along with urapidil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Gagało, I; Szreder, Z | 1 |
| Ramage, AG | 1 |
| Bruning, TA; Van Zwieten, PA | 1 |
| Chaouche-Teyara, K; Dabiré, H; Fournier, B; Lacolley, P; Safar, ME | 1 |
| Brussee, H; Stoschitzky, G; Stoschitzky, K; Wonisch, M | 1 |
| Araki, M; Araki, T; Monden, K | 1 |
| Arcas Bellas, JJ; López Pérez, V; Mesa Ruiz, JL; Tebar Cuesta, MY | 1 |
2 trial(s) available for doxazosin and urapidil
| Article | Year |
|---|---|
Differential effects of urapidil and doxazosin on heart rate.
Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Doxazosin; Heart Rate; Humans; Male; Piperazines | 2007 |
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
7 other study(ies) available for doxazosin and urapidil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
The effect of doxazosin, urapidil and indoramin pretreatment on fever produced by E. coli lipopolysaccharide in rabbits.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature Regulation; Doxazosin; Escherichia coli; Female; Fever; Indoramin; Lipopolysaccharides; Male; Piperazines; Prazosin; Rabbits | 1991 |
A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats.
Topics: Action Potentials; Animals; Blood Pressure; Cats; Doxazosin; Male; Piperazines; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Vascular Resistance | 1986 |
Comparison of the hemodynamic effects of urapidil and flesinoxan in healthy volunteers.
Topics: Adult; Antihypertensive Agents; Arginine; Dose-Response Relationship, Drug; Doxazosin; Hemodynamics; Humans; Male; Methoxamine; omega-N-Methylarginine; Piperazines; Regional Blood Flow; Serotonin; Vascular Resistance | 1994 |
Relationship between arterial distensibility and low-frequency power spectrum of blood pressure in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Autonomic Nervous System; Blood Pressure; Carotid Artery, Common; Doxazosin; Echocardiography, Doppler; Male; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sympathetic Nervous System; Vascular Capacitance | 2002 |
Management of hypertensive crisis with clevidipine in the perioperative setting of a critically ill patient, non-responder to high doses of nitroglycerin, labelatol, urapidil, doxazosin and furosemide.
Topics: Critical Illness; Doxazosin; Furosemide; Humans; Nitroglycerin; Piperazines; Pyridines | 2021 |